{"DataElement":{"publicId":"2684335","version":"3","preferredName":"Dose Bevacizumab Adverse Event Modification Type","preferredDefinition":"the type of adverse event, any unfavorable or unintended symptom, sign, or disease including an abnormal laboratory finding, the required a modification in the amount of bevacizumab, a monoclonal antibody that may prevent the growth of blood vessels from surrounding tissue to a solid tumor, that may or may not be considered related to that medical treatment or procedure.","longName":"DOS_BEV_AE_MOD_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2517526","version":"1","preferredName":"Dose Bevacizumab Adverse Event Modification","preferredDefinition":"information related to dose modification due to any unfavorable or unintended symptom, sign, or disease including an abnormal laboratory finding temporally associated with the use of bevacizumab, a monoclonal antibody that may prevent the growth of blood vessels from surrounding tissue to a solid tumor, that may or may not be considered related to that medical treatment or procedure.","longName":"DOSE_BEV_AE_MOD","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2411801","version":"1","preferredName":"Dose","preferredDefinition":"The amount of medicine taken, or radiation given, at one time.","longName":"C25488","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"019C7266-B63E-0AAA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-09-27","modifiedBy":"ONEDATA","dateModified":"2005-09-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2517524","version":"1","preferredName":"Bevacizumab Adverse Event Modification","preferredDefinition":"A monoclonal antibody that may prevent the growth of blood vessels from surrounding tissue to a solid tumor.:Any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation. The term also is referred to as an adverse experience. The old term Side Effect is retired and should not be used.:Modification; the act of making something different.","longName":"C2039:C41331:C25572","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bevacizumab","conceptCode":"C2039","definition":"A recombinant humanized monoclonal antibody directed against the vascular endothelial growth factor (VEGF), a pro-angiogenic cytokine.  Bevacizumab binds to VEGF and inhibits VEGF receptor binding, thereby preventing the growth and maintenance of tumor blood vessels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Modification","conceptCode":"C25572","definition":"Modification; the act of making something different.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C6ABE82-2108-23D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-09-01","modifiedBy":"ONEDATA","dateModified":"2006-09-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C6ABE82-2119-23D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-09-01","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2684340","version":"1","preferredName":"Adverse Event Modification Type","preferredDefinition":"the type of adverse event the required a modification of treatment or dose.","longName":"AE_MOD_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2567790","version":"1","preferredName":"Other","longName":"2567790","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D5DB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"KUMMEROA","dateModified":"2023-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3AE3EE33-A06F-31C3-E044-0003BA3F9857","beginDate":"2007-09-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-24","modifiedBy":"CAMPBELB","dateModified":"2007-09-24","deletedIndicator":"No"},{"value":"Wound Dehiscence","valueDescription":"Wound Dehiscence","ValueMeaning":{"publicId":"2580695","version":"1","preferredName":"Wound Dehiscence","longName":"2580695","preferredDefinition":"Separation of the layers of a surgical wound; it may be partial and superficial only, or complete with disruption of all layers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Wound Dehiscence","conceptCode":"C50863","definition":"Splitting of the sutured margins of a surgical wound. Risk factors include diabetes mellitus, obesity, and advanced age.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0844-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-08-28","modifiedBy":"ONEDATA","dateModified":"2006-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3AE3EE33-A07B-31C3-E044-0003BA3F9857","beginDate":"2007-09-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-24","modifiedBy":"CAMPBELB","dateModified":"2007-09-24","deletedIndicator":"No"},{"value":"Proteinuria","valueDescription":"Proteinuria","ValueMeaning":{"publicId":"2562565","version":"1","preferredName":"Proteinuria","longName":"2562565v1.00","preferredDefinition":"The presence of abnormal amounts of protein in the urine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Proteinuria","conceptCode":"C38012","definition":"The presence of abnormal amounts of protein in the urine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C172-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-04","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-10-04","modifiedBy":"KUMMEROA","dateModified":"2023-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3AE3EE33-A088-31C3-E044-0003BA3F9857","beginDate":"2007-09-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-24","modifiedBy":"CAMPBELB","dateModified":"2007-09-24","deletedIndicator":"No"},{"value":"Hemorrhage","valueDescription":"Hemorrhage","ValueMeaning":{"publicId":"2684341","version":"1","preferredName":"Hemorrhage","longName":"2684341","preferredDefinition":"Bleeding or escape of blood from a vessel.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemorrhage","conceptCode":"C26791","definition":"The flow of blood from a ruptured blood vessel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AE3EE33-A095-31C3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3AE3EE33-A0AE-31C3-E044-0003BA3F9857","beginDate":"2007-09-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-24","modifiedBy":"CAMPBELB","dateModified":"2007-09-24","deletedIndicator":"No"},{"value":"Thrombosis/Embolism","valueDescription":"Thrombosis","ValueMeaning":{"publicId":"2684342","version":"1","preferredName":"Thrombosis","longName":"2684342","preferredDefinition":"(throm-BOW-sis) The formation or presence of a blood clot inside a blood vessel.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thrombosis","conceptCode":"C26891","definition":"The formation of a blood clot in the lumen of a vessel or heart chamber; causes include coagulation disorders and vascular endothelial injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AE3EE33-A0BA-31C3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3AE3EE33-A0D3-31C3-E044-0003BA3F9857","beginDate":"2007-09-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-24","modifiedBy":"CAMPBELB","dateModified":"2007-09-24","deletedIndicator":"No"},{"value":"GI Toxicity","valueDescription":"GI toxicity","ValueMeaning":{"publicId":"2571816","version":"1","preferredName":"GI toxicity","longName":"2571816","preferredDefinition":"GI toxicity","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E595-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-08","modifiedBy":"CAMPBELB","dateModified":"2004-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3AE51965-8BE2-3B04-E044-0003BA3F9857","beginDate":"2007-09-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-24","modifiedBy":"ONEDATA","dateModified":"2007-09-24","deletedIndicator":"No"},{"value":"Cardiac Toxicity","valueDescription":"Cardiac Toxicity","ValueMeaning":{"publicId":"2684343","version":"1","preferredName":"Cardiac Toxicity","longName":"2684343","preferredDefinition":"Cardiac Toxicity","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AE5174E-8DAE-37C3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3AE51965-8BF4-3B04-E044-0003BA3F9857","beginDate":"2007-09-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-24","modifiedBy":"ONEDATA","dateModified":"2007-09-24","deletedIndicator":"No"},{"value":"Renal Toxicity","valueDescription":"Renal toxicity","ValueMeaning":{"publicId":"2571819","version":"1","preferredName":"Renal toxicity","longName":"2571819","preferredDefinition":"Renal toxicity","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E598-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-08","modifiedBy":"CAMPBELB","dateModified":"2004-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3AE51965-8C06-3B04-E044-0003BA3F9857","beginDate":"2007-09-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-24","modifiedBy":"ONEDATA","dateModified":"2007-09-24","deletedIndicator":"No"},{"value":"Hepatic Toxicity","valueDescription":"Hepatic Toxicity","ValueMeaning":{"publicId":"2580728","version":"1","preferredName":"Hepatic Toxicity","longName":"2580728","preferredDefinition":"Hepatic Toxicity","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0865-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-09-01","modifiedBy":"CAMPBELB","dateModified":"2006-09-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3AE51965-8C12-3B04-E044-0003BA3F9857","beginDate":"2007-09-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-24","modifiedBy":"ONEDATA","dateModified":"2007-09-24","deletedIndicator":"No"},{"value":"Hematologic Toxicity","valueDescription":"HEMATOLOGIC TOXICITY","ValueMeaning":{"publicId":"2565918","version":"1","preferredName":"HEMATOLOGIC TOXICITY","longName":"2565918","preferredDefinition":"HEMATOLOGIC TOXICITY","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CE8B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-05-09","endDate":null,"createdBy":"CVALMONT","dateCreated":"2003-05-09","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3AE51965-8C1E-3B04-E044-0003BA3F9857","beginDate":"2007-09-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-24","modifiedBy":"ONEDATA","dateModified":"2007-09-24","deletedIndicator":"No"},{"value":"Neurotoxicity","valueDescription":"Neurotoxicity","ValueMeaning":{"publicId":"2580731","version":"1","preferredName":"Neurotoxicity","longName":"2580731v1.00","preferredDefinition":"A group of neurologic disorders caused by damage to the nervous system following exposure to pharmacologic, biologic, and chemical agents. Examples of neurotoxins include chemotherapy agents, radiation treatment, heavy metals, pesticides, and food additives.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neurotoxicity Syndrome","conceptCode":"C27961","definition":"A group of neurologic disorders caused by damage to the nervous system following exposure to pharmacologic, biologic, and chemical agents. Examples of neurotoxins include chemotherapy agents, radiation treatment, heavy metals, pesticides, and food additives.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0868-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-09-01","modifiedBy":"KUMMEROA","dateModified":"2023-09-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3AE5220E-A31F-3AD5-E044-0003BA3F9857","beginDate":"2007-09-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-24","modifiedBy":"ONEDATA","dateModified":"2007-09-24","deletedIndicator":"No"},{"value":"Arterial Thrombotic Event","valueDescription":"Arterial Thrombotic Event","ValueMeaning":{"publicId":"2580730","version":"1","preferredName":"Arterial Thrombotic Event","longName":"2580730","preferredDefinition":"Arterial Thrombotic Event","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0867-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-09-01","modifiedBy":"CAMPBELB","dateModified":"2006-09-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3AE5220E-A32B-3AD5-E044-0003BA3F9857","beginDate":"2007-09-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-24","modifiedBy":"ONEDATA","dateModified":"2007-09-24","deletedIndicator":"No"},{"value":"Venous Thrombosis/Embolism","valueDescription":"Venous Thrombosis/Embolism","ValueMeaning":{"publicId":"2580729","version":"1","preferredName":"Venous Thrombosis/Embolism","longName":"2580729","preferredDefinition":"Venous Thrombosis/Embolism","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0866-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-09-01","modifiedBy":"CAMPBELB","dateModified":"2006-09-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3AE5220E-A337-3AD5-E044-0003BA3F9857","beginDate":"2007-09-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-24","modifiedBy":"ONEDATA","dateModified":"2007-09-24","deletedIndicator":"No"},{"value":"Allergic reaction/hypersensitivity","valueDescription":"Allergic reaction/hypersensitivity","ValueMeaning":{"publicId":"2692141","version":"1","preferredName":"Allergic reaction/hypersensitivity","longName":"2692141","preferredDefinition":"Allergic reaction/hypersensitivity","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3DA86063-1C63-4DDA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3DA8611B-236E-293F-E044-0003BA3F9857","beginDate":"2007-10-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-10-29","modifiedBy":"ONEDATA","dateModified":"2007-10-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008554","version":"1","preferredName":"Treatment/Off-treatment Reasons","preferredDefinition":"justification for or explanation of the administration or cessation of therapy.","longName":"TX_OTX_RSNS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2C9BE32-8BDB-649C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AE3EE2E-6CB5-2E46-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-24","modifiedBy":"SHIDED","dateModified":"2011-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Adverse Event","type":"Preferred Question Text","description":"Adverse Event","url":null,"context":"CTEP"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3AE3851E-2456-1765-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-24","modifiedBy":"CAMPBELB","dateModified":"2008-04-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}